tubulin[1]
[1]. Wang Q, et al. Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin. J Med Chem. 2019 Jul 12.
[2]. Qinghui Wang, et al. Discovery of ABI-231 analogs targeting the colchicine site in tubulin for advanced melanoma. Cancer Research 76(14 Supplement):4848-4848.
[3]. Vivek Kashyap, et al. ABI-231: A novel small molecule suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting Human papilloma virus (HPV) E6 and E7. Cancer Research 78(13 Supplement):679-679.
VERU-111 (ABI-231) 是一種高效、口服可利用 α/β 微管蛋白 (tubulin) 抑制劑,具有很強(qiáng)的抗增殖活性,對(duì)黑素瘤和前列腺癌細(xì)胞系 panel 作用的平均 IC50 值為 5.2 nM。VERU-111 (ABI-231) 通過(guò)靶向 HPV E6 和 E7 抑制腫瘤生長(zhǎng)和轉(zhuǎn)移表型,還具有治療前列腺癌的潛力。
河南威梯希化工科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
劉經(jīng)理